Trial NCT04052204

View at ClinicalTrials.gov 
Org. Study IDs: B9991040
Secondary IDs: 2019-001358-24

Last trial update was posted on 2021-10-14

MeSH Interventions

Avelumab Talazoparib

MeSH Conditions

Squamous Cell Carcinoma of Head and Neck

Other Conditions

Metastatic Castration Resistant Prostate Cancer (mCRPC) Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Stopping Reasons

Study prematurely terminated as the experimental treatments evaluated in study B9991040 may not provide additional clinical benefit over current or future Standard of Care in the different therapeutic indications that this trial was to evaluate.

Limitations And Caveats

Phase 1b part of Combination A was conducted but not completed as company terminated this study on 21 May 2021. Termination was not due to a regulatory request or new emerging safety signals. Test for Combination B, Combination C and Phase 2 expansion for Combination A planned in the protocol were not conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID